{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:55:40Z","timestamp":1787136940857,"version":"build-2736575974"},"reference-count":54,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32141003"],"award-info":[{"award-number":["32141003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2021YFC2301100"],"award-info":[{"award-number":["2021YFC2301100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["32141003"],"award-info":[{"award-number":["32141003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2301100"],"award-info":[{"award-number":["2021YFC2301100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background: Intracellular bacteria frequently result in chronic and recurrent infections. MRSA is one of the most prevalent facultative intracellular bacteria in clinical infections. The drug resistance of MRSA and the difficulty of most antibiotics in entering cells result in a suboptimal clinical efficacy of antibiotics in the treatment of intracellular MRSA. Bacteriophages represent a promising alternative therapy in the context of the current antimicrobial resistance crisis. Nevertheless, the low efficiency of phage entry into cells and their rapid inactivation remain challenges in the treatment of intracellular MRSA using phages. The utilization of functionalized carriers for the delivery of phages into cells and their protection represents a feasible strategy. Methods: In this study, a new MRSA bacteriophage (vB_SauS_PHM) was isolated from hospital sewage, exhibiting the characteristics of short incubation period, large lytic amount, and good environmental tolerance. Subsequently, vB_SauS_PHM was encapsulated by TAT peptide-functionalized liposomes through microfluidic technology and size-exclusion chromatography (SEC), forming a phage delivery system, designated TAT-Lip@PHM. Results: The encapsulation rate of the phage by TAT-Lip@PHM was 20.3%, and the cell entry efficiency was \u226590% after 8 h. The 24 h eradication rate of 300 \u03bcg\/mL TAT-Lip@PHM against intracellular MRSA was 94.05% (superior to the 21.24% and 44.90% of vB_SauS_PHM and Lip@PHM, respectively), while the mammalian cell activity was &gt;85% after 24 h incubation. Conclusions: The TAT-Lip@PHM effectively delivered the phage into the cell and showed an excellent killing effect on intracellular MRSA with low cytotoxicity. This work provides a technical reference for the application of phages in the treatment of intracellular bacterial infection.<\/jats:p>","DOI":"10.3390\/pharmaceutics17060743","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T08:34:32Z","timestamp":1749112472000},"page":"743","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A TAT Peptide-Functionalized Liposome Delivery Phage System (TAT-Lip@PHM) for an Enhanced Eradication of Intracellular MRSA"],"prefix":"10.3390","volume":"17","author":[{"given":"Kaixin","family":"Liu","sequence":"first","affiliation":[{"name":"Chinese PLA Center for Disease Control and Prevention, Beijing 100071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[{"name":"The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Guo","sequence":"additional","affiliation":[{"name":"Chinese PLA Center for Disease Control and Prevention, Beijing 100071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Chinese PLA Center for Disease Control and Prevention, Beijing 100071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Liu","sequence":"additional","affiliation":[{"name":"Chinese PLA Center for Disease Control and Prevention, Beijing 100071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Song","sequence":"additional","affiliation":[{"name":"Chinese PLA Center for Disease Control and Prevention, Beijing 100071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-2405","authenticated-orcid":false,"given":"Rongtao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Chinese PLA Center for Disease Control and Prevention, Beijing 100071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2109789","DOI":"10.1002\/adma.202109789","article-title":"Cascade-Targeting Poly (amino acid) Nanoparticles Eliminate Intracellular Bacteria via On-Site Antibiotic Delivery","volume":"34","author":"Feng","year":"2022","journal-title":"Adv. Mater."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.06.007","article-title":"Biodistribution and intracellular localization of hyaluronan and its nanogels. A strategy to target intracellular S. aureus in persistent skin infections","volume":"326","author":"Montanari","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Soe, Y.M., Bedoui, S., Stinear, T.P., and Hachani, A. (2021). Intracellular Staphylococcus aureus and host cell death pathways. Cell. Microbiol., 23.","DOI":"10.1111\/cmi.13317"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/cmdc.202000677","article-title":"Therapeutic Strategies to Counteract Antibiotic Resistance in MRSA Biofilm-Associated Infections","volume":"16","author":"Cascioferro","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature16057","article-title":"Novel antibody\u2013antibiotic conjugate eliminates intracellular S. aureus","volume":"527","author":"Lehar","year":"2015","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1751-7915.14217","article-title":"First-in-human application of double-stranded RNA bacteriophage in the treatment of pulmonary Pseudomonas aeruginosa infection","volume":"16","author":"Li","year":"2023","journal-title":"Microb. Biotechnol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jobm.201800412","article-title":"Bacteriophages: An overview of the control strategies against multiple bacterial infections in different fields","volume":"59","author":"Jamal","year":"2019","journal-title":"J. Basic Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Weber-D\u0105browska, B., \u017baczek, M., \u0141obocka, M., \u0141usiak-Szelachowska, M., Owczarek, B., Orwat, F., \u0141odej, N., Skaradzi\u0144ska, A., \u0141aczma\u0144ski, \u0141., and Martynowski, D. (2023). Characteristics of Environmental Klebsiella pneumoniae and Klebsiella oxytoca Bacteriophages and Their Therapeutic Applications. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020434"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Balc\u00e3o, V.M., Belline, B.G., Silva, E.C., Almeida, P.F.F.B., Baldo, D.\u00c2., Amorim, L.R.P., Oliveira J\u00fanior, J.M., Vila, M.M.D.C., and Del Fiol, F.S. (2022). Isolation and Molecular Characterization of Two Novel Lytic Bacteriophages for the Biocontrol of Escherichia coli in Uterine Infections: In Vitro and Ex Vivo Preliminary Studies in Veterinary Medicine. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14112344"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kevin, S., Wolfgang, P., Alex, K., and HansPeter, H. (2021). Synergy between Phage Sb-1 and Oxacillin against Methicillin-Resistant Staphylococcus aureus. Antibiotics, 10.","DOI":"10.3390\/antibiotics10070849"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Fei, T., Xiaoyu, X., Songsong, Z., Guiwei, L., Ruichong, W., Lanlan, Z., Xiaona, W., Han, Z., Jiaxuan, L., and Yijing, L. (2022). Efficacy Assessment of Phage Therapy in Treating Staphylococcus aureus-Induced Mastitis in Mice. Viruses, 14.","DOI":"10.3390\/v14030620"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Jonathan, S., Wenqian, W.E., Dustin, G., Joseph, F., Bri\u2019Anna, H., Theodore, M., and Doub, J.B. (2022). Successful Use of Salvage Bacteriophage Therapy for a Recalcitrant MRSA Knee and Hip Prosthetic Joint Infection. Pharmaceuticals, 15.","DOI":"10.3390\/ph15020177"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Doub, J.B., Ng, V.Y., Myounghee, L., Andrew, C., Alina, L., Silvia, W., and Benjamin, C. (2022). Salphage: Salvage Bacteriophage Therapy for Recalcitrant MRSA Prosthetic Joint Infection. Antibiotics, 11.","DOI":"10.3390\/antibiotics11050616"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: A systematic review","volume":"22","author":"Uyttebroek","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1128\/AEM.00812-15","article-title":"Liposome-Encapsulated Bacteriophages for Enhanced Oral Phage Therapy against Salmonella spp","volume":"81","author":"Colom","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Poerio, N., Olimpieri, T., De Angelis, H.L., De Santis, F., Thaller, M.C., D\u2019Andrea, M.M., and Fraziano, M. (2022). Fighting MDR-Klebsiella pneumoniae Infections by a Combined Host- and Pathogen-Directed Therapeutic Approach. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.835417"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1080\/10717544.2016.1177136","article-title":"Pharmaceutical liposomal drug delivery: A review of new delivery systems and a look at the regulatory landscape","volume":"23","author":"Zylberberg","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kaur, S., Kumari, A., Kumari Negi, A., Galav, V., Thakur, S., Agrawal, M., and Sharma, V. (2021). Nanotechnology based approaches in phage therapy: Overcoming the pharmacological barriers. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.699054"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cinquerrui, S., Mancuso, F., and Malik, D.J. (2018). Nanoencapsulation of bacteriophages in liposomes prepared using microfluidic hydrodynamic flow focusing. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.02172"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Shan, S., Jia, S., Lawson, T., Yan, L., Lin, M., and Liu, Y. (2019). The use of TAT peptide-functionalized graphene as a highly nuclear-targeting carrier system for suppression of choroidal melanoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184454"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/cphc.202000873","article-title":"Cell-Penetrating Peptides: Correlation between Peptide-Lipid Interaction and Penetration Efficiency","volume":"22","author":"Choong","year":"2021","journal-title":"ChemPhysChem"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1021\/acs.molpharmaceut.2c00523","article-title":"Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges","volume":"19","author":"Parrasia","year":"2022","journal-title":"Mol. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00380-18","DOI":"10.1128\/AEM.00380-18","article-title":"A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice","volume":"84","author":"Wang","year":"2018","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e00646-23","DOI":"10.1128\/msystems.00646-23","article-title":"Engineered phage with cell-penetrating peptides for intracellular bacterial infections","volume":"8","author":"Zhao","year":"2023","journal-title":"mSystems"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1365-2672.2011.04989.x","article-title":"Isolation and characterization of lytic bacteriophages against enterohaemorrhagic Escherichia coli","volume":"110","author":"Viazis","year":"2011","journal-title":"J. Appl. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"198080","DOI":"10.1016\/j.virusres.2020.198080","article-title":"Isolation and characterization of Vibrio parahaemolyticus bacteriophage vB_VpaS_PG07","volume":"286","author":"Ding","year":"2020","journal-title":"Virus Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Adriaenssens, E., and Brister, J.R. (2017). How to Name and Classify Your Phage: An Informal Guide. Viruses, 9.","DOI":"10.1101\/111526"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2018.04.063","article-title":"Microfluidic-assisted bacteriophage encapsulation into liposomes","volume":"545","author":"Leung","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2174\/1381612821666150115144003","article-title":"DSPE-PEG: A distinctive component in drug delivery system","volume":"21","author":"Che","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fmicb.2021.602902","article-title":"JD419, a Staphylococcus aureus Phage with a Unique Morphology and Broad Host Range","volume":"12","author":"Feng","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jconrel.2023.03.053","article-title":"Bacteria-mimetic nanomedicine for targeted eradication of intracellular MRSA","volume":"357","author":"Xie","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"119784","DOI":"10.1016\/j.ijpharm.2020.119784","article-title":"Enhanced eradication of intracellular and biofilm-residing methicillin-resistant Staphylococcus aureus (MRSA) reservoirs with hybrid nanoparticles delivering rifampicin","volume":"589","author":"Guo","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2017.08.007","article-title":"Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages","volume":"267","author":"Pei","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/acsabm.8b00821","article-title":"Antibiotic-Derived Lipid Nanoparticles to Treat Intracellular Staphylococcus aureus","volume":"2","author":"Zhang","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-016-0294-z","article-title":"The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation","volume":"8","author":"Langdon","year":"2016","journal-title":"Genome Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e00066-18","DOI":"10.1128\/CMR.00066-18","article-title":"Phage Therapy in the Postantibiotic Era","volume":"32","author":"Altamirano","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Fabijan, A.P., Lin, R.C.Y., Ho, J., Maddocks, S., Ben Zakour, N.L., Iredell, J.R., Khalid, A., Venturini, C., Chard, R., and Morales, S. (2020). Publisher Correction: Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat. Microbiol., 5.","DOI":"10.1038\/s41564-020-0698-9"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/07315724.2018.1483783","article-title":"Bacteriophage for Gastrointestinal Health (PHAGE) Study: Evaluating the Safety and Tolerability of Supplemental Bacteriophage Consumption","volume":"38","author":"Gindin","year":"2019","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_41","first-page":"100115","article-title":"Phage therapy in the Covid-19 era: Advantages over antibiotics","volume":"3","author":"Khan","year":"2022","journal-title":"Curr. Res. Microb. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Doss, J., Culbertson, K., Hahn, D., Camacho, J., and Barekzi, N. (2017). A Review of Phage Therapy against Bacterial Pathogens of Aquatic and Terrestrial Organisms. Viruses, 9.","DOI":"10.3390\/v9030050"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"109145","DOI":"10.1016\/j.lwt.2020.109145","article-title":"Characterization of two novel lytic bacteriophages for reducing biofilms of zoonotic multidrug-resistant Staphylococcus aureus and controlling their growth in milk","volume":"124","author":"Gharieb","year":"2020","journal-title":"LWT"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.3168\/jds.2024-24540","article-title":"Development and mouse model evaluation of a new phage cocktail intended as an alternative to antibiotics for treatment of Staphylococcus aureus-induced bovine mastitis","volume":"107","author":"Guo","year":"2024","journal-title":"J. Dairy Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11259-018-9736-y","article-title":"Isolation and characterization of two lytic bacteriophages against Staphylococcus aureus from India: Newer therapeutic agents against Bovine mastitis","volume":"42","author":"Ganaie","year":"2018","journal-title":"Vet. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000515282","article-title":"Isolation and Characterization of a Lytic Staphylococcus aureus Phage WV against Staphylococcus aureus Biofilm","volume":"64","author":"Jiang","year":"2021","journal-title":"Intervirology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"113864","DOI":"10.1016\/j.addr.2021.113864","article-title":"Formulation strategies for bacteriophages to target intracellular bacterial pathogens","volume":"176","author":"Yan","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Bispo, M., Santos S\u00edlvio, B., Melo Lu\u00eds, D.R., Azeredo, J., and van Dijl, J.M. (2022). Targeted Antimicrobial Photodynamic Therapy of Biofilm-Embedded and Intracellular Staphylococci with a Phage Endolysin\u2019s Cell Binding Domain. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.01466-21"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.coviro.2021.12.009","article-title":"Endocytosis of Bacteriophages","volume":"52","author":"Miernikiewicz","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/15216540500494508","article-title":"Properties of cell penetrating peptides (CPPs)","volume":"58","author":"Kerkis","year":"2006","journal-title":"IUBMB Life"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zong, W., Shao, X., Li, J., Cai, Z., and Zhang, X. (2024). Towards a biomimetic cellular structure and physical morphology with liposome-encapsulated agarose sol systems. Int. J. Biol. Macromol., 264.","DOI":"10.1016\/j.ijbiomac.2024.130418"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zong, W., Shao, X., Chai, Y., Wang, X., Han, S., Chu, H., Zhu, C., and Zhang, X. (2022). Liposomes encapsulating artificial cytosol as drug delivery system. Biophys. Chem., 281.","DOI":"10.1016\/j.bpc.2021.106728"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jare.2022.09.007","article-title":"Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells","volume":"49","author":"Zhu","year":"2023","journal-title":"J. Adv. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"121452","DOI":"10.1016\/j.ijpharm.2022.121452","article-title":"Anti-inflammatory effects of free and liposome-encapsulated Algerian thermal waters in RAW 264.7 macrophages","volume":"614","author":"Mokdad","year":"2022","journal-title":"Int. J. Pharm."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/6\/743\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:47:04Z","timestamp":1760032024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/6\/743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["pharmaceutics17060743"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17060743","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]}}}